Efficacy of Edupression.Com® in Depressive Patients

Summary

The aim of the study is to investigate the efficacy and adherence of the digital self-help programme edupression.com®.

Conditions

• Depressive; Episode, Major
• Recurrent Depressive Disorder, Current Episode Moderate
• Recurrent Depressive Disorder, Current Episode Mild

Interventions

OTHER

edupression.com®

Edupression.com® is an evidence-based self-help program that was developed for the treatment of mild to moderate unipolar depression. It is based on two core foundations, psychoeducation with elements of cognitive behavior therapy (CBT) and a mood chart. Both foundations are registered as a medical product. As such, detailed risk management documentation includes probability and severity of adverse events. Moreover, detailed strategies such as warnings were implemented in the software and documented accordingly. It can be used on a PC as well as on mobile devices (browser, App) at any time.

OTHER

Health tips

Interventions that do not directly target depression: general health tips (diet, lifestyle, smoking, etc.), occupational health interventions (back pain prevention, breaks,...), etc.

DIAGNOSTIC_TEST

Surveys

Quizzes and surveys for course monitoring (including suicidality), but without extensive reports.

OTHER

Popular psychological interventions

Popular psychological interventions, which have not been shown to be effective in studies: Affirmation phrases, motivational sayings and quotes (known also from calendars), tests (e.g., Rorschach interpretation), exercises (emotion recognition of faces), multimedia content (pleasant music, landscape images, interviews of famous people with depression), etc.

Sponsors & Collaborators

• Medical University of Vienna

  lead OTHER

Principal Investigators

• Markus Dold, MD, Priv.Doz. · Medical University of Vienna

• Lukas M Pezawas, MD, Prof. · Medical University of Vienna

• Gabriele Fischer, MD, Prof. · Medical University of Vienna

• Lucie Bartova, MD · Medical University of Vienna

Study Design

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Model

PARALLEL

Eligibility

Min Age

18 Years

Max Age

65 Years

Sex

ALL

Healthy Volunteers

No

Timeline & Regulatory

Start

2021-04-28

Primary Completion

2023-04-11

Completion

2023-07-04

Countries

• Austria

Study Locations